These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 2822902

  • 1. Effect of pH on the inhibition of angiotensin converting activity by enalaprilat in the rat perfused mesenteric vascular bed.
    Lindsey CJ, Bendhack LM, Paiva AC.
    J Pharmacol Exp Ther; 1987 Oct; 243(1):292-6. PubMed ID: 2822902
    [Abstract] [Full Text] [Related]

  • 2. Effects of teprotide, captopril and enalaprilat on arterial wall kininase and angiotensin converting activity.
    Lindsey CJ, Bendhack LM, Paiva AC.
    J Hypertens Suppl; 1987 Jul; 5(2):S71-6. PubMed ID: 2821209
    [Abstract] [Full Text] [Related]

  • 3. Potentiation of bradykinin effect by angiotensin-converting enzyme inhibition does not correlate with angiotensin-converting enzyme activity in the rat mesenteric arteries.
    Sivieri DO, Bispo-da-Silva LB, Oliveira EB, Resende AC, Salgado MC.
    Hypertension; 2007 Jul; 50(1):110-5. PubMed ID: 17470724
    [Abstract] [Full Text] [Related]

  • 4. Angiotensin-(1-7) potentiates responses to bradykinin but does not change responses to angiotensin I.
    Greco AJ, Master RG, Fokin A, Baber SR, Kadowitz PJ.
    Can J Physiol Pharmacol; 2006 Nov; 84(11):1163-75. PubMed ID: 17218981
    [Abstract] [Full Text] [Related]

  • 5. Role of PGI2 and effects of ACE inhibition on the bradykinin potentiation by angiotensin-(1-7) in resistance vessels of SHR.
    Fernandes L, Fortes ZB, Casarini DE, Nigro D, Tostes RC, Santos RA, de Carvalho MH.
    Regul Pept; 2005 Apr 15; 127(1-3):183-9. PubMed ID: 15680485
    [Abstract] [Full Text] [Related]

  • 6. Effects of neutral endopeptidase inhibition and combined angiotensin converting enzyme and neutral endopeptidase inhibition on angiotensin and bradykinin peptides in rats.
    Campbell DJ, Anastasopoulos F, Duncan AM, James GM, Kladis A, Briscoe TA.
    J Pharmacol Exp Ther; 1998 Nov 15; 287(2):567-77. PubMed ID: 9808682
    [Abstract] [Full Text] [Related]

  • 7. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors.
    Linz W, Wiemer G, Gohlke P, Unger T, Schölkens BA.
    Pharmacol Rev; 1995 Mar 15; 47(1):25-49. PubMed ID: 7784479
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of angiotensin-converting enzyme inhibition on arterial, venous and capillary functions in cat skeletal muscle in vivo.
    Ekelund U.
    Acta Physiol Scand; 1996 Sep 15; 158(1):29-37. PubMed ID: 8876745
    [Abstract] [Full Text] [Related]

  • 10. Effect of chronic angiotensin converting enzyme inhibition on angiotensin I and bradykinin metabolism in rats.
    Stanziola L, Greene LJ, Santos RA.
    Am J Hypertens; 1999 Oct 15; 12(10 Pt 1):1021-9. PubMed ID: 10560789
    [Abstract] [Full Text] [Related]

  • 11. Regulation of regional vascular tone: the role of angiotensin conversion in human forearm resistance vessels.
    Webb DJ, Collier JG, Seidelin PH, Struthers AD.
    J Hypertens Suppl; 1988 Dec 15; 6(3):S57-9. PubMed ID: 2852237
    [Abstract] [Full Text] [Related]

  • 12. Roles of the two active sites of somatic angiotensin-converting enzyme in the cleavage of angiotensin I and bradykinin: insights from selective inhibitors.
    Georgiadis D, Beau F, Czarny B, Cotton J, Yiotakis A, Dive V.
    Circ Res; 2003 Jul 25; 93(2):148-54. PubMed ID: 12805239
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pharmacological properties of the new non-sulfhydryl angiotensin converting enzyme inhibitor N-[8-amino-1(S)-carboxyoctyl]-L-alanyl-L-proline.
    Shirota M, Kajiwara Y, Iijima M, Kitabatake K.
    Arzneimittelforschung; 1990 May 25; 40(5):515-9. PubMed ID: 2166521
    [Abstract] [Full Text] [Related]

  • 15. Effect of zinc depletion on angiotensin I-converting enzyme in arterial walls and plasma of the rat.
    Dahlheim H, White CL, Rothemund J, von Lutterotti N, Jacob IC, Rosenthal J.
    Miner Electrolyte Metab; 1989 May 25; 15(3):125-9. PubMed ID: 2542744
    [Abstract] [Full Text] [Related]

  • 16. Do the cardiovascular effects of angiotensin-converting enzyme (ACE) I involve ACE-independent mechanisms? new insights from proline-rich peptides of Bothrops jararaca.
    Ianzer D, Santos RA, Etelvino GM, Xavier CH, de Almeida Santos J, Mendes EP, Machado LT, Prezoto BC, Dive V, de Camargo AC.
    J Pharmacol Exp Ther; 2007 Aug 25; 322(2):795-805. PubMed ID: 17475904
    [Abstract] [Full Text] [Related]

  • 17. Effect of angiotensin-converting enzyme two-week inhibition on renal angiotensin II receptors and renal vascular reactivity in SHR.
    Haddad G, Garcia R.
    J Mol Cell Cardiol; 1997 Feb 25; 29(2):813-22. PubMed ID: 9140837
    [Abstract] [Full Text] [Related]

  • 18. Interaction between neutral endopeptidase and angiotensin converting enzyme inhibition in rats with myocardial infarction: effects on cardiac hypertrophy and angiotensin and bradykinin peptide levels.
    Duncan AM, James GM, Anastasopoulos F, Kladis A, Briscoe TA, Campbell DJ.
    J Pharmacol Exp Ther; 1999 Apr 25; 289(1):295-303. PubMed ID: 10087017
    [Abstract] [Full Text] [Related]

  • 19. ACE inhibitor potentiation of bradykinin-induced venoconstriction.
    Hecker M, Blaukat A, Bara AT, Müller-Esterl W, Busse R.
    Br J Pharmacol; 1997 Aug 25; 121(7):1475-81. PubMed ID: 9257930
    [Abstract] [Full Text] [Related]

  • 20. The effect of local angiotensin converting enzyme inhibition on the action of atrial natriuretic peptide in the human forearm.
    Cockcroft JR, Allen MJ, Benjamin N, Webb DJ.
    J Hum Hypertens; 1989 Feb 25; 3(1):49-52. PubMed ID: 2542549
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.